Inventor · disambiguated record
Laurence R. Meyerson
Also filed as: MEYERSON LAURENCE R
24 granted patents·38 pending applications·622 citations·filing 2004–2021
98Inventor score
Files withADAMAS PHARMACEUTICALS INC30WENT GREGORY T10MEYERSON LAURENCE R9ADAMAS PHARMA LLC4CARDIOVASCULAR BIOTHERAPEUTICS INC4
Top patents by PatentIndex Score
62 records- 0198US8987333B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Mar 24, 2015·20 cites·11 claims
- 0298US8895617B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·17 claims
- 0398US8895618B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·12 claims
- 0498US8895616B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·14 claims
- 0598US8895615B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·16 claims
- 0698US8895614B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·11 claims
- 0798US8889740B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 18, 2014·21 cites·9 claims
- 0898US8796337B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2013·Granted Aug 5, 2014·27 cites·14 claims
- 0998US8389578B2Composition and method for treating neurological diseaseWENT GREGORY T·Filed 2005·Granted Mar 5, 2013·94 cites·8 claims
- 1098US7619007B2Method and composition for administering an NMDA receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2005·Granted Nov 17, 2009·53 cites·20 claims
- 1197US8580858B2Compositions for the treatment of CNS-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2012·Granted Nov 12, 2013·22 cites·10 claims
- 1297US8426472B2Method and composition for administering an NMDA receptor antagonist to a subjectWENT GREGORY T·Filed 2011·Granted Apr 23, 2013·20 cites·10 claims
- 1397US8362085B2Method for administering an NMDA receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2012·Granted Jan 29, 2013·33 cites·12 claims
- 1497US8338486B2Methods for the treatment of CNS-related conditionsWENT GREGORY T·Filed 2012·Granted Dec 25, 2012·24 cites·12 claims
- 1597US8338485B2Compositions for the treatment of CNS-related conditionsWENT GREGORY T·Filed 2012·Granted Dec 25, 2012·23 cites·16 claims
- 1697US8293794B2Methods and compositions for the treatment of CNS-related conditionsWENT GREGORY T·Filed 2010·Granted Oct 23, 2012·24 cites·28 claims
- 1797US8283379B2Methods and compositions for the treatment of CNS-related conditionsWENT GREGORY T·Filed 2010·Granted Oct 9, 2012·33 cites·15 claims
- 1897US8168209B2Method and composition for administering an NMDA receptor antagonist to a subjectWENT GREGORY T·Filed 2009·Granted May 1, 2012·35 cites·15 claims
- 1996US8598233B2Method for administering an NMDA receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2013·Granted Dec 3, 2013·21 cites·18 claims
- 2096US8329752B2Composition for administering an NMDA receptor antagonist to a subjectWENT GREGORY T·Filed 2012·Granted Dec 11, 2012·24 cites·16 claims
- 2196US8173708B2Method and composition for administering an NMDA receptor antagonist to a subjectWENT GREGORY T·Filed 2010·Granted May 8, 2012·24 cites·18 claims
- 2288US10966610B2Angiogenic treatment of ischemic heart diseaseCARDIOVASCULAR BIOTHERAPEUTICS INC·Filed 2017·Granted Apr 6, 2021·5 cites·15 claims
- 2386US9968292B2Therapeutic angiogenesis for treating erectile conditionsCARDIOVASCULAR BIOTHERAPEUTICS INC·Filed 2017·Granted May 15, 2018·9 cites·20 claims
- 2474US2014135529A1Method for administering an nmda receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2572US2010022659A1Methods and Compositions for the Treatment of CNS-Related ConditionsMEYERSON LAURENCE R·Filed 2009·Application pending·0 cites
- 2672US2013165517A1Composition and Method for Treating Neurological DiseaseADAMAS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2771US2010029665A1Methods and Compositions for Treating Migraine PainMEYERSON LAURENCE R·Filed 2009·Application pending·0 cites
- 2871US2017281565A1Composition for Administering an NMDA Receptor Antagonist to a SubjectADAMAS PHARMA LLC·Filed 2016·Application pending·0 cites
- 2970US2018263914A1Compositions for the treatment of cns-related conditionsADAMAS PHARMA LLC·Filed 2017·Application pending·0 cites
- 3070US2009253728A1Methods and Compositions for Treating Nociceptive PainMEYERSON LAURENCE R·Filed 2008·Application pending·0 cites
- 3169US2014336266A1Method for administering an nmda receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3269US2009234021A1Treatment of Demyelinating ConditionsLIPTON STUART A·Filed 2008·Application pending·0 cites
- 3367US2014134243A1Compositions for the Treatment of CNS-Related ConditionsADAMAS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3467US2014179797A1Composition for Administering an NMDA Receptor Antagonist to a SubjectADAMAS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3566US2016243093A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3666US2016250149A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3766US2016243094A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3866US2016243035A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3966US2016220545A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4066US2016243058A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4166US2016250161A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4266US2016243095A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4365US2012288560A1Methods for the Treatment of CNS-Related ConditionsWENT GREGORY T·Filed 2012·Application pending·0 cites
- 4464US2017056340A1Composition for Administering an NMDA Receptor Antagonist to a SubjectADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4563US2019201354A1Composition for administering an nmda receptor antagonist to a subjectADAMAS PHARMA LLC·Filed 2019·Application pending·0 cites
- 4662US2010292216A1Methods and Compositions for the Treatment of Psychiatric ConditionsADAMAS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4762US2015297537A1Compositions for the Treatment of CNS-Related ConditionsADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4861US2006240043A1Methods and compositions for treating migraine painMEYERSON LAURENCE R·Filed 2005·Application pending·0 cites
- 4961US2005065219A1Treatment of demyelinating conditionsFiled 2004·Application pending·0 cites
- 5060US2006052370A1Methods and compositions for treating nociceptive painMEYERSON LAURENCE R·Filed 2005·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Laurence R. Meyerson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →